Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Maternal urogenital schistosomiasis; monitoring disease morbidity by simple reagent strips

Abstract

Background

Urine analysis is one of the recommended antenatal guidelines for early diagnosis of pregnancy-associated complications. While in practice, urine analysis by dipstick had been used to provide useful information on other urinary tract infections, its applications for early detection of urogenital schistosomiasis in pregnant women is often times not given due attention in most endemic areas. Our study therefore assessed the performance of some common urinalysis parameters in the diagnosis of maternal urogenital schistosomiasis in endemic rural communities of Nigeria.

Methodology/Principal findings

The cross-sectional epidemiologic survey of urogenital schistosomiasis was conducted among pregnant women in Yewa North Local Government, Ogun State, Nigeria. The women were microscopically examined for infection with Schistosoma haematobium, visually observed for macrohematuria, and screened for microhematuria and proteinuria using standard urine chemical reagent strips. Of 261 volunteered participants, 19.9% tested positive for S. haematobium infection. The proportion of microhematuria (23.8%) was significantly higher than that of macrohematuria (3.8%) and proteinuria (16.8%) (P<0.05). Microhematuria with sensitivity (82.7%) and specificity (89.0%) was the best diagnostic indicator of urogenital schistosomiasis. Macrohematuria with the least sensitivity (11.8%) was however the most specific (98.1%) for diagnosing urogenital schistosomiasis in pregnant women. Maximum microhematuria sensitivity (100.0%) was observed in women between 15–19 years but sensitivity was consistently low in older age groups. Maximum sensitivity, specificity and predictive values (100.0%) were recorded for microhematuria in first trimester women. Diagnostic efficiency of proteinuria and macrohematuria was also better in the first trimester women except the 25.0% specificity recorded for proteinuria. The overall diagnostic performance of microhematuria and proteinuria was better in secundigravidae.

Conclusions/Significance

Microhematuria can be used for early detection of urogenital schistosomiasis in endemic areas especially in younger women. However because microhematuria is a condition that occurs during pregnancy and in several other diseases, it is necessary to compliment the diagnosis with other diagnostic tools such as microscopy and serology. Treatment with praziquantel is recommended for the women in their late trimesters after follow up test in order to avert associated adverse pregnancy outcomes.

Introduction

Schistosomiasis is a public health problem in low resource poor countries of the world due to lack of access to health facilities and safe water, poor hygiene and sanitation. The disease is caused by Schistosoma spp. Schistosma mansoni and S. haematobium are the two predominant species in sub-Saharan Africa causing human disease. The earlier causes intestinal and hepatic schistosomiasis while the later which is thought to affect the urinary and genital organs causes urogenital schistosomiasis. With the over 260 million infected people in the world [1] and about 97% of all schistosomiasis infections arising from African continent [2], prompt diagnosis for rational control is necessary. Although it is a disease often associated with children [36], studies have shown that other population groups are also at risk of Schistosoma infection [7,8,9]. Pregnant women in most endemic areas of Africa are at risk due to involvement in domestic work that requires unsafe water exposure. The last decade estimated population of infected pregnant women totalled 10 million [10]. With increasing reports on Schistosoma infection during pregnancy [9,1115], management of infected pregnant women through treatment with praziquantel in late trimesters has been advocated in order to avert undesirable pregnancy outcomes [16]. Despite recommendations from WHO, many endemic countries are reluctant to include it because of the side effects [10]. Besides pregnancy associated morbidities, female genital involvement associated with S. haematobium infection characterized by symptoms like pelvic discomfort, vaginal discharge, sandy patches in mucosa, edema, and contact bleeding [17] could be presented in non-pregnant and pregnant women alike.

The choice of a rapid diagnostic test is dependent on the following; affordability, sensitivity, specificity, user-friendliness, rapidity and robustness, equipment free and deliverability to end-users [18]. Presently, the only commercially available rapid immunodiagnostic kit for schistosomiasis, the lateral flow urine-CCA dipstick showed very poor performance with the detection of S. haematobium [19,20], while the lateral flow urine-CAA dipstick originally designed for S. haematobium is not yet available for public use. This is further supported by a meta-analysis of different studies in Africa on performance of dipstick diagnosis of S. haematobium [21,22].

Urine analysis is one of the recommended antenatal screenings for early diagnosis of pregnancy-associated complications. In practice, urine analysis by dipstick had been used to provide useful information on other urinary tract infections such as cystitis and urethritis, but its applications for early detection of maternal urogenital schistosomiasis is often times down played in most endemic areas. There are several reports on performance of simple reagent strips for the diagnosis of urogenital schistosomiasis in many sub-Sahara African countries [47,23]. Many studies on diagnostic performance of reagent strips in the general population usually included women of reproductive age, although few are specifically focus on this group [24,25], while no study, to the best of our knowledge, has been specifically conducted on pregnant women. Prompt monitoring of the disease in pregnant women through the use of avoidable and easy to use chemical reagent dipsticks in low resource endemic rural areas becomes very imperative for effective management and to avert the often schistosomiasis-associated undesirable pregnancy outcomes such as low birth weight, prenatal and maternal death [26].

Hematuria is a recognized as pathological condition of urogenital schistosomiasis and its detection using reagent strips had long been suggested as a simple and rapid means of screening large populations [27,28]. While proteinuria is also a useful indirect diagnostic indicator of urogenital schistosomiasis, its application during pregnancy may be undermined by some common abnormal pregnancy conditions such as preeclampsia. These biomarkers of infection due to S. haematobium are known to correlate with the intensity of infection [29]. Our study therefore assessed the performance of these urinalysis parameters in the diagnosis of maternal urogenital schistosomiasis in endemic rural communities of Nigeria.

Materials and methods

Ethical statement

Permission was sought from the communities’ leaders prior study. Communities’ heads and primary health care workers were contacted in advance of the survey to ensure maximum participation of the pregnant women. Written informed consent was obtained from the women. Study was voluntary and participants were permitted to opt out at any time. Ethical approval (UI/EC/11/0052) was obtained from the joint ethical review committee of University College Hospital and University of Ibadan, Ibadan, Nigeria. Infected pregnant women in second and third trimesters were administered a single dose of 40 mg/kg praziquantel [10]. The first trimester women were treated at the later stage of their pregnancy.

Study area

The study was conducted in Yewa North Local Government Area (LGA). It forms part of the epidemiological studies on urogenital schistosomiasis conducted among pregnant women between February 1, 2010 and February 15, 2011 [9]. As previously described in several studies carried out in the study area, transmission of schistosomiasis is aided by lack of potable water supply and presence of snails intermediate hosts of schistosomes [9,15,2931].

Study design and sample size determination

The study was descriptive and cross-sectional. Participants were recruited according to an already described procedure in our previous study [9]. Briefly, the LGA was divided into 10 wards based on the presence of functional primary health care centers. Subjects were then sourced from these health centers using a convenient random sampling. Written informed consents were obtained from the participants. Non-regular dwellers were excluded from the study. A minimum sample size 223 as determined by the method of Daniel [32] using a 0.05 (5%) precision and 80% statistical power was computed. A 30% prevalence of urogenital schistosomiasis obtained from a total of 30 pregnant women randomly selected in a pilot study was also used for sample size determination [9].

Rapid diagnostic tests and parasitological examination

Collection and examination of urine samples was done according to previously described procedures [6,9]. Fresh mid-day single urine sample each collected from 261 participants by trained personnel in a pre-labeled sterile universal bottle between the hour of 10 and 14 o’clock was inspected for gross hematuria (macrohematuria) and then screened for microhematuria and proteinuria using urine reagent strip (Medi-Test Combi 9®, Neumann-Neander-Str. 6–8. D-52355 Düren). The urinalysis was performed according to the manufacturer’s instructions. The diagnostic performance of the morbidity indicators of urogenital schistosomiasis was determined. The samples were transported to the Parasitology Research Unit Laboratory of the Department of Zoology, University of Ibadan for further analysis. The sample was mixed and 10 mL of the sample was centrifuged. The sediment was observed under the light microscope after removal of supernatant for the presence of terminally spined S. haematobium eggs.

Statistical analysis

The data were entered into an Excel spread sheet (version 2007) and transferred to GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA) for analyses. Data were categorized into age group (15–19, 20–24, 25–29, ≥ 30 years), trimester and parity. Chi square and Fisher’s exact tests were used to determine the significant differences in proportion of urogenital schistosomiasis in subjects positive and negative for pathological indicators of the disease. Diagnostic performances of reagent strips in different categories of data were determined by calculating sensitivity, specificity, positive and negative predictive values and areas under the receiver operating characteristic (ROC) curves. Urine microscopy was used as the gold standard. P-values < 0.05 were considered statistically significant.

Results

Associations between schistosomiasis and morbidity indicators in pregnant women

The distribution of urogenital schistosomiasis and morbidity indicators of the disease in the observed subjects relative to age, trimester and gravidity was presented in Table 1. Infection due to S. haematobium was associated with macrohematuria and microhematuria (P <0.05) (Table 2). While infection statuses were significantly higher in microhematuria positive group compared with those without microhematuria (P <0.0001) across age groups, no significant variations were recorded for infection statuses in macrohematuria and proteinuria across different groups (P >0.05). The association between urogenital schistosomiasis and indicators of infection stratified by age, trimester and gravidity is presented in Table 3.

thumbnail
Table 1. Population characteristics and infection statuses by microscopy and urinary indicators of urogenital schistosomiasis.

https://doi.org/10.1371/journal.pone.0187433.t001

thumbnail
Table 2. Association between urogenital schistosomiasis and indicators of infection in pregnant women.

https://doi.org/10.1371/journal.pone.0187433.t002

thumbnail
Table 3. Association between urogenital schistosomiasis and indicators of infection stratified by age, trimester and gravidity.

https://doi.org/10.1371/journal.pone.0187433.t003

Diagnostic performance and pregnant women age

The diagnostic performance of dipsticks relative to the age of pregnant women is presented in Table 4. Maximum microhematuria sensitivity (100.0%) was observed in women between 15–19 years but sensitivity was consistently low in other older age groups. Sensitivity of the tested diagnostic indicators seemed to decrease with increase in age of the pregnant women except in women ≥ 30 years (Table 5). Maximum specificity and positive predictive values (100%) were recorded for macrohematuria in pregnant women in age 15–19 years. While the sensitivity of proteinuria was consistently higher than that of macrohematuria across different age groups, the reverse was the case for specificity (Table 5).

thumbnail
Table 4. Performance of urinary morbidity indicators in diagnosis of urogenital schistosomiasis in pregnant women.

https://doi.org/10.1371/journal.pone.0187433.t004

thumbnail
Table 5. Effect of pregnant women age on diagnostic potential of urinary indicators of urogenital schistosomiasis.

https://doi.org/10.1371/journal.pone.0187433.t005

Diagnostic performance and trimesters

Maximum sensitivity, specificity and predictive values (100.0%) were recorded for microhematuria in first trimester women. Diagnostic efficiency of proteinuria and macrohematuria was also better in the first trimester women except the 25.0% specificity recorded for proteinuria (Table 6). The highest sensitivity (90.0%) was recorded in secundigravidae.

thumbnail
Table 6. Effect of gestational age on diagnostic potential of urinary indicators of urogenital schistosomiasis.

https://doi.org/10.1371/journal.pone.0187433.t006

Diagnostic performance and parity

The sensitivities for proteinuria which ranged from 23–33% and macrohematuria 8–14% were consistently low in all parity groups (Table 7). The specificity (approximately 92.0%) and positive predictive value (75.0%) of microhematuria was similar among the primigravid and secundigravid women. The overall diagnostic performance of microhematuria (OR = 120.0) and proteinuria (OR = 5.7) was best in secundigravidae.

thumbnail
Table 7. Effect of parity on diagnostic potential of urinary indicators of urogenital schistosomiasis.

https://doi.org/10.1371/journal.pone.0187433.t007

Discussion

Epidemiological studies abound on urogenital schistosomiasis in sub-Saharan Africa. Little is however known about maternal schistosomiasis in the region. While efforts have recently been made to address this issue in pregnant women [8,9,11,12,31], there are still more to be done for effective management of the disease in the group. Quick detection of the disease in pregnant women is necessary to avert the associated morbidities, which could cause impairment in pregnancy outcomes. Simple reagent strips, often used to monitor medical conditions of pregnant women during antenatal care, could become a very useful tool for quick diagnosis of schistosomiasis for rational control measure.

Urogenital schistosomiasis is a public health problem among pregnant women in the study area. The influence of pregnancy characteristics (i.e. age, trimester, and parity), lack of potable water and socio-cultural belief in regards to transmission had been widely discussed [9,31]. Urogenital schistosomiasis has long been considered as one of the causes of hematuria in endemic communities [25,28]. Schistosoma-associated hematuria results from bladder lesions that result from the deposition of the parasite’s spiny eggs in the submucosa [33]. The lack of significant association between hematuria and ages of the pregnant women showed equal predisposition to the condition irrespective of age.

Macrohematuria (visible blood in urine) is used as an indirect rapid diagnostic marker for urogenital schistosomiasis in resource poor rural settings without the availability of urine reagent strips [3436]. Therefore, the 98.1% specificity observed in this study is consistent with the findings of the aforementioned studies. However, most of those studies were performed on school-based cohorts. The sensitivity of macrohematuria in our study was lower than the mostly reported values in school children [4] but higher than that of a study on preschool children and infants [6]. Gross hematuria increased with increase burden of S. haematobium infection; an observation similar to previous reports [37,38]. The association reported between infection due to S. haematobium and microhematuria suggests that it is a good biomarker for infection in pregnant women in endemic areas. This is evident in the high sensitivity and specificity values obtained in our study. Other possible causes of microhematuria which could have led to some false positive results have been suggested to be idiopathic hematuria; peculiar changes in the urogenital tract induced by hormonal and mechanical factors of pregnancy [39,40] and urinary tract infections [41].

The lack of associations between occurrence of proteinuria in S. haematobium infected and non-infected pregnant women is similar to a report among women of child-bearing age in Tanzania [25]. Aside the various set backs undermining the use of proteinuria and other indirect diagnostic indicators of urogenital schistosomiasis in women, some of which include genitourinary infection and/or the sequelae of genital mutilation [25] and preeclampsia could become a major concern in false positive proteinuria outcomes in pregnant women. Preeclampsia which is often characterized by significant proteinuria during pregnancy is multifactorial including cerebral vasoconstriction, ischemia and vasogenicedema [42], thus a suspected urogenital schistosomiasis-induced proteinuria by dipsticks in pregnant women must be confirmed by microscopy. Occurrence of genitourinary infection and preeclampsia could have resulted in the very poor sensitivity and positive predictive values of proteinuria obtained in our study. High false positivity of proteinuria could have serious implication for preeclampsia management in schistosomiasis endemic areas as the pregnant women may be deprived of the right attention.

The diagnostic performance of reagent strips was greatly influenced by ages of the pregnant women. However, a deviation from the general age-related diagnostic performance in ≥ 30 years needs to be further explored. With maximum sensitivity (100%) and a very high specificity (96.3%) of microhematuria in 15–19 years pregnant women, reagent strips become a very useful tool for diagnosis of S. haematobium in the group. This success could be attributed to higher S. haematobium burden in term of intensity of infection in the group. However, more studies are required to ascertain this. Accuracy of reagent strips results had also been reported to be influenced by age and sex of children [43]. Early detection of infection in first trimester can be suggested owning to improved diagnostic performance in the group. This better performance in the group can be related to the reason claimed for the younger pregnant women as earlier mentioned. However, the low number of first trimester participants poses a limitation and thus necessitates further studies. The higher urogenital schistosomiasis detection rate in women in their early trimester which was hypothesized to be related to a lesser frequency of micturition compared to the late trimester women [9] could facilitate easy detection of pathology indicators of the disease. This also could have serious implication on control as disease could progress chronic in nature in late trimesters especially where there is no repeated or fresh exposure to schistosome parasites. Poor performance of hematuria in late trimester however could be due to lower burden of S. haematobium in term of intensity as shown in our result. While higher parasite burden could be responsible for the better diagnostic performance of microhematuria in primigravidae.

One limitation in this study was the fact that other confounders such as urinary tract infections, idiopathic hematuria or preeclampsia which could also be associated with these urine biomarkers were not considered in the study design. Observations inferred from this study may not be applicable to other population settings. The cross-sectional nature of our study failed to assess variations in presentation of the disease markers with time, thus might have influenced diagnostic performance. Evaluation of macrohaematuria repeatedly over a period of a few days is expected to increase its accuracy [4]. A single urine sample collected and the use of centrifugation method to concentrate parasites rather than the usually recommended filtration method could result in under-presentation of true infection status.

Conclusion

We observed one fifth of the pregnant women to be infected with S. haematobium in Yewa North LGA, Ogun State, Nigeria. Microhematuria becomes a useful rapid diagnostic tool for the disease in young pregnant women. However because microhematuria is a condition that occurs during pregnancy and in several other diseases, it is necessary to compliment the diagnosis with other diagnostic tools such as microscopy and serology. Diagnosis of schistosomiasis during early pregnancy stage is recommended and this should be introduced to routine antenatal care in Schistosoma-endemic areas. Pregnant women at the later stage of pregnancy should only be treated with praziquantel after confirmatory tests are conducted in order to forestall S. haematobium-induced adverse pregnancy outcomes.

Acknowledgments

We acknowledge the co-operation and participation of the women recruited for this study, the communities’ heads and the primary health care workers.

References

  1. 1. World Health Organisation. Schistosomiasis: progress report 2001–2011, strategic plan 2012–2020. Geneva: WHO, 2013. http://who.int (accessed Aug 23, 2017).
  2. 2. Utzinger J, Raso G, Brooker S, de Savigny D, Tanner M, Ornbjerg BH, et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitol 2009; 136: 1859–1874. https://doi.org/10.1017/S0031182009991600
  3. 3. Kapito-Tembo AP, Mwapasa V, Meshnick SR, Samanyika Y, Banda D, Bowie C, et al. Prevalence Distribution and Risk Factors for Schistosoma haematobium Infection among School Children in Blantyre, Malawi. PLoS Negl Trop Dis. 2009;3(1): e361. pmid:19156193
  4. 4. Ugbomoiko US, Ofoezie IE, Okoye IC, Heukelbach J. Factors associated with urinary schistosomiasis in two peri-urban communities in south–western Nigeria. Ann Trop Med Parasitol 2010; 104(5): 409–419. http://dx.doi.org/10.1179/136485910X12743554760469 pmid:20819309
  5. 5. Morenikeji O, Junaid Q, Omoregie C, Hassan A, Nwuba R, Anumudu C, et al. Cross-sectional study on urogenital schistosomiasis in children; haematuria and proteinuria as diagnostic indicators in an endemic rural area of Nigeria. Afr Hlth Sci. 2014; 14(2): 390–396.
  6. 6. Salawu OT, Odaibo AB. Urogenital schistosomiasis and urological assessment of hematuria in preschool-aged children in rural communities of Nigeria. J Ped Urol 2014; 10(1): 88–93. http://dx.doi.org/10.1016/j.jpurol.2013.06.010
  7. 7. Koukounari A, Webster JP, Donnelly CA, Bray BC, Naples J, Bosompem K, et al. Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium. Estimated from data on adults in villages Northwest of Accra, Ghana. Am J Trop Med Hyg 2009; 80(3): 435–441. pmid:19270295
  8. 8. Eyo JE, Onyishi GC, Okafor FC. Urinary schistosomiasis among pregnant women in some endemic tropical semi-urban communities of Anambra State, Nigeria. Trop Biomed 2012; 29(4): 575–579 pmid:23202602
  9. 9. Salawu OT, Odaibo AB. Schistosomiasis among pregnant women in rural communities in Nigeria. Int J Gynecol Obstet 2013; 122(1):1–4. http://dx.doi.org/10.1016/j.ijgo.2013.01.024
  10. 10. World Health Organization. Report of the WHO Informal Consultation on the use of Praziquantel during Pregnancy/Lactation and Albendazole/Mebendazole in Children under 24 months. http://whqlibdoc.who.Int/hq/2003/WHO-CDS-CPE-PVC-2002.4.pdf. Published 2003.
  11. 11. Khalid A, Abdelgadir MA, Ashmaig A, Ibrahim AM, Ahmed AA, Adam I. Schistosoma mansoni infection among prenatal attendees at a secondary-care hospital in central Sudan. Int J Gynecol Obstet 2012; 116: 10–12. http://dx.doi.org/10.1016/j.ijgo.2011.08.018
  12. 12. Basra A, Mombo-Ngoma G, Melser MC, Diop DA, Würbel H, Mackanga JR, et al. Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. Clin Inf Dis 2013; 56: 68–75. pmid:23175561
  13. 13. Adegnika AA, Ramharter M, Agnandji ST, Ngoa UA, Issifou S, Yazdanbahksh M, et al. Epidemiology of parasitic coinfections during pregnancy in Lambaréné, Gabon. Trop Med Intl Health. 2010; 15: 1204–1219. pmid:20636299
  14. 14. Thigpen MC, Filler SJ, Kazembe PN, Parise ME, Macheso A, Campbell CH, et al. Associations between peripheral Plasmodium falciparum malaria parasitemia, human immunodeficiency virus, and concurrent helminthic infection among pregnant women in Malawi. Am J Trop Med Hyg. 2011; 84: 379–385. pmid:21363973
  15. 15. Salawu OT, Odaibo AB. The bionomics and diversity of freshwater snail species in Yewa North, Ogun State, Southwestern Nigeria. Helminthologia, 2014b; 51(4): 337–344.
  16. 16. World Health Organization. Report of the WHO Informal Consultation on the use of Praziquantel during Pregnancy/Lactation and Albendazole/Mebendazole in Children under 24 months. http://whqlibdoc.who.int/hq/2003/WHO_CDS_CPE_PVC_2002.4.pdf. Published 2003.
  17. 17. Kjetland EF, Leutscher PD, Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol 2012; 28: 58–65. pmid:22245065
  18. 18. Stothard JR. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans R Soc Trop Med Hyg 2009; 103: 325–332. pmid:19171359
  19. 19. Stothard JR, Kabatereine NB, Tukahebwa EM, Kazibwe F, Rollinson D, Mathieson W, et al. Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop 2006; 97: 219–228. http://dx.doi.org/10.1016/j.actatropica.2005.11.004 pmid:16386231
  20. 20. Ayele B, Erko B, Legesse M, Hailu A, Medhin G. Evaluation of circulating cathodic antigen (CCA) strip for diagnosis of urinary schistosomiasis in Hassoba school children, Afar, Ethiopia. Parasit 2008; 15: 69–75. pmid:18416249
  21. 21. King CH, Bertsch KD. Meta-analysis of urine heme dipstick diagnosis of Schistosoma haematobium infection, including low-prevalence and previously-treated populations. PLoS Negl Trop Dis 2013; 7(9): e2431. doi. pmid:24069486
  22. 22. Ochondo EA, Gopalakrishna G, Spek B, Reitsma JB, Lieshout P, Bossuyt PMM, et al. Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas. Cochrane Database Syst Rev 2015; 3. Art.No.: CD009579. pmid:25758180
  23. 23. Krauth SJ, Greter H, Stete K, Coulibaly JT, Traoré SI, Ngandolo BNR, et al. All that is blood is not schistosomiasis: experiences with reagent strip testing for urogenital schistosomiasis with special consideration to very-low prevalence settings. Parasit Vect. 2015;8:584. pmid:26554822
  24. 24. Gundersen SG, Kjetland EF, Poggessee G, Helling-Giese G, Richter J, Chitsulo L, et al. Urine reagent strips for diagnosis of schistosomiasis haematobium in women of fertile age. Acta Trop. 1996; 62: 281–287. pmid:9028412
  25. 25. Poggensee G, Krantz I, Kiwelu I, Feldmeier H. Screening of Tanzanian women of child bearing age for urinary schistosomiasis: validity of urine reagent strip readings and self-reported symptoms. Bull World Health Organ. 2000; 78(4); 542–548. pmid:10885183
  26. 26. Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD. Schistosomiasis and pregnancy. Trends Parasitol 2007; 23(4): 159–164. pmid:17336160
  27. 27. Wilkins HA, Gall P, Marshall TF, de C, Moore P. The significance of proteinuria and haematuria in Schistosoma haematobium infection. Trans R Soc Trop Med Hyg 1979; 73: 74–80. pmid:442186
  28. 28. Mott KE, Dixon H, Osei-Tutu E, England EC. Relationship between intensity of Schistosoma haematobium infection and clinical haematuria and proteinuria. Lancet, 1983;May 7:1005–1008. pmid:6133057
  29. 29. Akinwale O, Oso O, Salawu O, Odaibo A, Tang P, Chen TW, et al. Molecular characterisation of Bulinus snails–intermediate hosts of schistosomes in Ogun state, South-western Nigeria. Folia Malacol 2015;23: 137–147
  30. 30. Salawu OT, Odaibo AB. Preliminary study on ecology of Bulinus jousseaumei snail in Schistosoma haematobium endemic rural community of Nigeria. Afr J Ecol 2012;51(3):441–446.
  31. 31. Salawu OT, Odaibo AB. Schistosomiasis transmission; socio-demographic, knowledge and practices as transmission risk factors in pregnant women. J Parasit Dis. 2016;40(1):93–99. pmid:27065605
  32. 32. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 7th ed. New York, NY: John Wiley & Sons; 1999.
  33. 33. Meurs L, Mbow M, Vereecken K, Menten J, Mboup S, Polman K. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: A Population-Wide Study in Northern Senegal. PLoS Negl Trop Dis 2012;6(9): e1829. pmid:23029589
  34. 34. Mafe MA, von Stamm T, Utzinger J, Goran EK, Goran N. Control of urinary schistosomiasis: an investigation into the effective use of questionnaires to identify high-risk communities and individuals in Niger State, Nigeria. Trop Med Int Health 2000;5:53–63. pmid:10672206
  35. 35. Anosike JC, Nwoke BEB, Njoku AJ. The validity of haematuria in the community diagnosis of urinary schistosomiasis infection. J Helminth 2001;75:223–225. https://doi.org/10.1079/JOH200048 pmid:11551310
  36. 36. Lengeler C, Utzinger J, Tanner M 2002. Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull World Health Organ 2002;80:235–242. pmid:11984610
  37. 37. Taylor P, Chandiwana SK, Matanhire D. Evaluation of the reagent strip test for haematuria in the control of Schistosoma haematobium infection in schoolchildren. Acta Trop 1990;47:91–100. pmid:1969705
  38. 38. Mafe MA. The diagnostic potential of three indirect tests for urinary schistosomiasis in Nigeria. Acta Trop 1997;68:277–284. http://dx.doi.org/10.1016/S0001-706X(97)00102-2 pmid:9492912
  39. 39. Danielli L, Korchazak D, Beyer H, Lotan M. Recurrent hematuria during pregnancies. Obs and Gyn 1987;69:446.
  40. 40. Venyo A. Recurrent haematuria in pregnancy: A case report and a review of the literature. WebmedCentral Urol 2010;1(12):WMC001341.
  41. 41. Jou WW, Powers RD. Utility of dipstick urinalysis as a guide to management of adults with suspected infection or hematuria. Southern Med J 1998;91(3): 266–269. pmid:9521367
  42. 42. Rudra P, Basak S, Patil D, Latoo MY. Recent advances in management of pre-emclapsia. BJMP 2011;4:a433
  43. 43. Guyatt H, Brooker S, Lwambo NJS, Siza JE, Bundy DAP. The performance of school-based questionnaires of reported blood in urine in diagnosing Schistosoma haematobium infection: patterns by age and sex. Trop Med Int Health 1999;4:751–757. pmid:10588769